Continuation or maintenance ECT for schizophrenia: A narrative review of case report data.

continuation electroconvulsive therapy electroconvulsive therapy maintenance electroconvulsive therapy review schizophrenia

Journal

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists
ISSN: 1440-1665
Titre abrégé: Australas Psychiatry
Pays: England
ID NLM: 9613603

Informations de publication

Date de publication:
28 May 2024
Historique:
medline: 28 5 2024
pubmed: 28 5 2024
entrez: 28 5 2024
Statut: aheadofprint

Résumé

This review aimed to address the limited evidence on the efficacy of continuation or maintenance electroconvulsive therapy (C/M-ECT) in schizophrenia, with a focus on international case reports and series due to the scarcity of randomised controlled trials. Electronic database searches were conducted to identify case reports or series evaluating the efficacy of C/M-ECT in patients with schizophrenia or schizoaffective disorder. C/M-ECT treatment span varied from 3 months to 36 years ( Collation of case reports and series data indicated that C/M-ECT, when combined with antipsychotics, appears to be a safe and effective strategy for maintaining remission, even over several years. Caution is warranted due to the potential influence of publication bias.

Identifiants

pubmed: 38805612
doi: 10.1177/10398562241256837
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10398562241256837

Déclaration de conflit d'intérêts

DisclosureThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Olivia Egan (O)

Westmead Clinical School, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

Daniel Talbot (D)

Western Sydney Local Health District, Westmead, NSW, Australia; and Specialty of Psychiatry, Sydney Medical School, Faculty of Medicine and Health Sciences, University of Sydney, Sydney, NSW, Australia.

Prashanth Mayur (P)

Western Sydney Local Health District, Westmead, NSW, Australia; and Specialty of Psychiatry, Sydney Medical School, Faculty of Medicine and Health Sciences, University of Sydney, Sydney, NSW, Australia.

Anthony Harris (A)

Western Sydney Local Health District, Westmead, NSW, Australia; Specialty of Psychiatry, Sydney Medical School, Faculty of Medicine and Health Sciences, University of Sydney, Sydney, NSW, Australia; and Brain Dynamics Centre, Westmead Institute for Medical Research, Westmead, NSW, Australia.

Classifications MeSH